Corbus Pharmaceuticals Hldgs Inc (CRBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Sales | 950 | 0 | 796 | 350 | 1,294 |
| Gross Profit | 950 | 0 | 796 | 350 | 1,294 |
| Operating Expenses | 12,815 | 10,862 | 7,753 | 7,642 | 8,746 |
| Operating Income | -11,865 | -10,862 | -6,957 | -7,292 | -7,453 |
| Other Income | 170 | 168 | -9 | -5 | -13 |
| Pre-tax Income | -11,695 | -10,694 | -6,966 | -7,297 | -7,465 |
| Net Income Continuous | -11,695 | -10,694 | -6,966 | -7,297 | -7,465 |
| Net Income | $-11,695 | $-10,694 | $-6,966 | $-7,297 | $-7,465 |
| EPS Basic Total Ops | -6.31 | -6.01 | -4.20 | -4.50 | -4.80 |
| EPS Basic Continuous Ops | -6.23 | -6.04 | -4.17 | -4.37 | -4.83 |
| EPS Diluted Total Ops | -6.31 | -6.01 | -4.20 | -4.50 | -4.80 |
| EPS Diluted Continuous Ops | -6.23 | -6.04 | -4.17 | -4.37 | -4.83 |
| EBITDA(a) | $-11,449 | $-10,797 | $-6,830 | $-7,259 | $-7,421 |